Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Income from Non-Controlling Interests (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Income from Non-Controlling Interests for 17 consecutive years, with -$1.0 million as the latest value for Q4 2025.

  • Quarterly Income from Non-Controlling Interests fell 125.0% to -$1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, down 93.33% year-over-year, with the annual reading at $2.0 million for FY2025, 86.67% down from the prior year.
  • Income from Non-Controlling Interests for Q4 2025 was -$1.0 million at Bristol Myers Squibb, up from -$6.0 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $8.0 million in Q1 2021, with the low at -$6.0 million in Q3 2025.
  • Average Income from Non-Controlling Interests over 5 years is $3.8 million, with a median of $4.0 million recorded in 2023.
  • The sharpest move saw Income from Non-Controlling Interests skyrocketed 220.0% in 2021, then crashed 250.0% in 2025.
  • Over 5 years, Income from Non-Controlling Interests stood at $6.0 million in 2021, then tumbled by 50.0% to $3.0 million in 2022, then soared by 100.0% to $6.0 million in 2023, then plummeted by 33.33% to $4.0 million in 2024, then plummeted by 125.0% to -$1.0 million in 2025.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at -$1.0 million, -$6.0 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.